PC

Partha Chakraborty

Active Director Designated Partner DIN 11289389
DIN 11289389 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Partha Chakraborty

Data last updated:

Partha Chakraborty is a Designated Partner at Scp Pharma Consultancy Llp (since 2025).

DIN 11289389
Primary Designation Designated Partner
First Appointment 09 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Sep 20252025Active

Board colleagues of Partha Chakraborty

NameDINCompanyDesignation
Chetan Dattatray Pachpor11289391Scp Pharma Consultancy LlpDesignated Partner
Sreenivas Satya Venkata Rompecherla11289390Scp Pharma Consultancy LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Scp Pharma Consultancy Llp
Premium access

Shareholding and investment profile for Partha Chakraborty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Partha Chakraborty

Partha Chakraborty currently holds 1 directorship: Scp Pharma Consultancy Llp (Designated Partner, since 09 Sep 2025).

Partha Chakraborty was first appointed on 09 Sep 2025 as Designated Partner at Scp Pharma Consultancy Llp.

The current boards of Partha Chakraborty's companies include Chetan Dattatray Pachpor (Scp Pharma Consultancy Llp), Sreenivas Satya Venkata Rompecherla (Scp Pharma Consultancy Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available